Creative Medical Technology Holdings Inc (CELZ)
4.16
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
4.165
0.00 (0.00%)
After-Hours: 20:00
Creative Medical Technology Holdings Cash from Financing (Quarterly): -0.0828M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.0828M |
December 31, 2023 | -0.271M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 15.47M |
March 31, 2022 | 0.00 |
December 31, 2021 | 9.307M |
September 30, 2021 | 2.810M |
June 30, 2021 | 0.1056M |
March 31, 2021 | 0.6186M |
December 31, 2020 | 0.2523M |
September 30, 2020 | 0.1757M |
June 30, 2020 | 0.1209M |
March 31, 2020 | 0.145M |
December 31, 2019 | 0.1828M |
September 30, 2019 | 0.3124M |
June 30, 2019 | 0.114M |
March 31, 2019 | 0.3884M |
December 31, 2018 | 0.4269M |
September 30, 2018 | 0.4193M |
June 30, 2018 | 0.243M |
March 31, 2018 | 0.2535M |
Date | Value |
---|---|
December 31, 2017 | 0.1152M |
September 30, 2017 | 0.0905M |
June 30, 2017 | 0.3757M |
March 31, 2017 | 0.10M |
December 31, 2016 | 0.3738M |
September 30, 2016 | 0.1386M |
June 30, 2016 | 0.1139M |
March 31, 2016 | 0.0507M |
December 31, 2015 | 0.0014M |
September 30, 2015 | 0.0025M |
June 30, 2015 | 0.005M |
March 31, 2015 | 0.005M |
December 31, 2014 | 0.005M |
September 30, 2014 | 0.0027M |
June 30, 2014 | 0.0053M |
March 31, 2014 | 0.005M |
December 31, 2013 | 0.0043M |
September 30, 2013 | 0.0037M |
June 30, 2013 | 0.0057M |
March 31, 2013 | 0.0089M |
December 31, 2012 | 0.0032M |
September 30, 2012 | 0.0042M |
June 30, 2012 | 0.0025M |
March 31, 2012 | 0.0065M |
December 31, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.271M
Minimum
Dec 2023
15.47M
Maximum
Jun 2022
1.463M
Average
0.1174M
Median
Cash from Financing (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.597M |
Palatin Technologies Inc | 9.136M |
iBio Inc | 5.025M |
Theriva Biologics Inc | 0.00 |
Oragenics Inc | 1.653M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.8969M |
Cash from Investing (Quarterly) | 6.520M |
Free Cash Flow | -5.083M |
Free Cash Flow Per Share (Quarterly) | -0.631 |
Free Cash Flow Yield | -86.59% |